#INFY futures on daily charts (0.25%) box size
- new highs
@pradytrader1 #FundManager call 😀
#smallminters

More from DTBhat
some recent highs taken out - watching for a close above 774
Also daily chart on 0.25% box size https://t.co/zjVX8UIXBq

#ICICIBANK chart is interesting.
— DTBhat (@dtbhat) July 10, 2022
On Renko charts - probable multi brick breakout on higher box size (3%) above 774 (on closing basis)
On P&F charts (3% boxsize) a probable triple top buy above 774
On shorter TF closing above 774 gives a close above 45 degree TL https://t.co/2xq4xumRgz pic.twitter.com/mULPwYdkv7
More from Infy

Infosys - Infy - The key is to keep trailing your Stop losses once the target is achieved and do not sell your winners. You never know what is going to come up. https://t.co/WPTHIyOUCq pic.twitter.com/sXBQwDqmZV
— Steve Nison (@nison_steve) August 5, 2021
You May Also Like
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj

@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
